Managing Ptosis with RVL-1201/Upneeq - Drs. Melissa Barnett, Susan Resnick & Jason Bacharach

In this ODwire.org webinar, Melissa Barnett, OD and Susan Resnick, OD will help us learn more about ptosis, including causes, diagnosis, treatment landscape, impact on patients, and opportunity for your practice.
Jason Bacharach, MD, will introduce the first and only FDA-approved pharmacologic treatment for acquired blepharoptosis, RVL-1201 (oxymetazoline hydrochloride ophthalmic solution), 0.1%, including its mechanism of action and clinical data.
--
ODwire.org: The Largest Online Community Exclusively for ECPs.
Always Free * Always Fun!
www.odwire.org

[@estherdelgado1167]

In case 3, did the male put a drop in both eyes or just the droopy eye? I'm waiting for my drops to arrive but wondered if I will need to put the drop in both eyes or just in the one that droops.

[@gauravmundhra4924]

Will this work with congenital ptosis. I had mri scan for my ptotic eye and everything is normal in the report